基于德尔菲法初步编制门诊慢性病患者参与用药安全能力自评量表
Preliminary Development of Self-assessment Scale for the Ability of Outpatients with Chronic Diseases to Participate in Medication Safety Based on the Delphi Method
背景 患者用药安全已成为世界重点关注的医疗卫生问题,患者对于促进自身用药安全发挥重要作用。目的 基于德尔菲法初步编制门诊慢性病患者参与用药安全能力自评量表,为评估及促进门诊慢性病患者参与用药安全能力提供客观标准。方法 通过文献研究和半结构化访谈法拟定门诊慢性病患者参与用药安全能力量表初始条目。根据研究目的,采用德尔菲法对来自北京、上海、广东、天津、浙江、内蒙古的 28 名专家进行两轮函询,请专家对维度的熟悉程度及判断依据进行评分,采用 Likert 5 级评分法对条目重要性及可行性进行评分。2021-09-30—10-12进行第一轮专家咨询,2021-11-05—15 进行第二轮专家咨询,最后通过专家小组会议讨论确定最终条目。计算问卷回收率,以此反映专家积极性;咨询结果的权威程度采用权威系数衡量;采用变异系数及协调系数 Kendall's W 评价专家意见协调程度;重要性和可行性评分的算术均数≥ 3.5 分且变异系数 <0.25 作为条目筛选的初步参考,同时结合专家意见,经研究小组成员和专家小组会议充分讨论后确定条目调整结果。结果 两轮专家咨询均发出 28 份问卷,回收问卷 28 份,专家积极系数均为 100%。两轮咨询专家权威系数为 0.877。第二轮条目重要性和可行性的专家意见协调系数 Kendall's W 相较第一轮均有所提高。第一轮专家咨询结果显示,各条目重要性评分为 3.964~4.964 分,变异系数为 0.038~0.211;可行性评分为 3.964~4.821 分,变异系数为 0.081~0.265。第二轮专家咨询结果显示,各条目的重要性评分为 4.321~5.000 分,变异系数为 0~0.168;可行性评分为 4.036~4.893 分,变异系数为 0.064~0.186。两轮专家咨询及专家小组会议后最终确定了包括用药知识、用药信念、参与用药决策、用药自我管理 4 个维度、33 个条目的门诊慢性病患者参与用药安全能力自评量表。结论 本研究构建了一个包含用药知识、用药信念、参与用药决策、用药自我管理 4 个维度、33 个条目的门诊慢性病患者参与用药安全能力自评量表,该自评量表能够对门诊慢性病患者参与用药安全能力进行评估,为制定相应措施以促进患者参与用药过程、提高用药安全提供参考。
Background Patient medication safety has become a global priority in healthcareand patients play an important role in promoting their own medication safety. Objective To develop a self-assessment scale for the ability of outpatients with chronic diseases to participate in medication safety based on the Delphi method and provide objective criteria for assessing and promoting their abilities to participate in medication safety. Methods A literature review and semi-structured interviews were used to formulate the initial entries of scale for the ability of outpatients with chronic diseases to participate in medication safety. According to the study objectives28 experts from BeijingShanghaiGuangdongTianjinZhejiang and Inner Mongolia participated in two rounds of correspondence using the Delphi methodand were asked to rate their familiarity and judgement basis of the dimensionsand the importance and feasibility of the items were rated using a fivepoint Likert scale. The first round of expert correspondence was conducted from 30 September to 12 October 2021and the second round was conducted from 5 to 15 November 2021. Final items of the scale were determined through an expert panel discussion. The questionnaire recovery rate was calculated as a reflection of expert motivationthe degree of authority of the correspondence results was measured using the authority coefficientthe degree of coordination of expert opinions was evaluated using the coefficient of variation and the coordination coefficient Kendall's W. The arithmetic mean of importance and feasibility scores ≥ 3.5 and coefficient of variation<0.25 were used as the initial reference for items selectionthe adjustments of the items were decided after the thorough discussions among the members of research team and the expert panel combining with the opinions of experts. Results In both rounds of correspondence28 questionnaires were sent out and 28 questionnaires were returnedwith a positive coefficient of 100% and the expert authority coefficient of 0.877. The expert coordination coefficient Kendall's W of the importance and the feasibility of items in the second round of correspondence increased compared to the first round of correspondence. The mean importance scores of items in the two rounds of the consultation ranged from 3.964 to 4.964 and 4.321 to 5.000with coefficients of variation from 0.038 to 0.211 and 0 to 0.168. The mean feasibility scores of the items in the two rounds of the consultation ranged from 3.964 to 4.821 and 4.036 to 4.893with coefficients of variation from 0.081 to 0.265 and 0.064 to 0.186respectively. The final self-assessment scale for the ability of outpatients with chronic diseases to participate in medication safety was determined after two rounds of expert correspondence and an expert panel discussionincluding 4 dimensions of medication knowledgemedication beliefparticipation in medication decision-makingand medication self-managementwith 33 items. Conclusion A self-assessment scale for the ability of outpatients with chronic diseases to participate in medication safety containing four dimensions of medication knowledgemedication beliefparticipation in medication decision-making and medication self-managementwith 33 itemswas constructed in the studywhich can assess the ability of outpatients with chronic diseases to participate in medication safety and provide a reference for developing appropriate measures to promote patient participation in the medication process and improve medication safety.
冯郑文、陈小垒、邵爽、李卉、杜娟、朱宸立
10.12114/j.issn.1007-9572.2023.0283
医药卫生理论医学研究方法药学
慢性病病人参与用药安全自我评价德尔菲技术
hronic diseasesPatient participationMedication safetySelf-evaluationelphi technique
冯郑文,陈小垒,邵爽,李卉,杜娟,朱宸立.基于德尔菲法初步编制门诊慢性病患者参与用药安全能力自评量表[EB/OL].(2023-09-19)[2025-08-02].https://chinaxiv.org/abs/202309.00198.点此复制
评论